• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估中国前列腺癌男性患者的癌症特异性焦虑:中文版纪念前列腺癌焦虑量表(MAX-PC)的心理测量学评估

Assessing cancer-specific anxiety in Chinese men with prostate cancer: psychometric evaluation of the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).

作者信息

Huang Qingmei, Jiang Ping, Zhang Zijun, Luo Jie, Dai Yun, Zheng Li, Wang Wei

机构信息

Department of Urology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, Zhejiang, 310003, China.

出版信息

Support Care Cancer. 2017 Dec;25(12):3683-3690. doi: 10.1007/s00520-017-3794-5. Epub 2017 Jun 22.

DOI:10.1007/s00520-017-3794-5
PMID:28643193
Abstract

PURPOSE

The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) was developed to identify and assess cancer-specific anxiety among men with prostate cancer (PCa); however, there is no Chinese version. The aim of our study was to translate the English version of MAX-PC into Chinese and evaluate the psychometric properties of it.

METHODS

The study cohort comprised 254 participants. Internal consistency including the Cronbach's alpha coefficient and item-total correlations were used to measure the reliability of the scale. Factor structure was analyzed by exploratory factor analysis and concurrent validity by comparing MAX-PC scores with anxiety subscale scores of the Hospital Anxiety and Depression Scale (HADS). Divergent validity was assessed by correlating MAX-PC with HADS depression subscale, while discriminant ability by comparing differences in MAX-PC scores between different patient groups.

RESULTS

The Chinese version of MAX-PC demonstrated good reliability; the Cronbach's alpha coefficient for the total and three subscales (prostate cancer anxiety, PSA anxiety, and fear of recurrence) being 0.94, 0.93, 0.82, and 0.85, respectively. Exploratory factor analysis supported the three-factor structure of the scale established in the original version. Despite the somewhat underperformed divergent validity, the scale demonstrated good concurrent validity with a strong correlation with the HADS anxiety subscale (r = 0.71, p < 0.01). Moreover, discriminant ability was demonstrated by ability to differentiate between disease stages.

CONCLUSIONS

The MAX-PC Chinese version was confirmed to be a valid, reliable instrument and is thus appropriate for identifying and quantifying cancer-specific anxiety in Chinese PCa patients.

摘要

目的

纪念斯隆凯特琳前列腺癌焦虑量表(MAX-PC)旨在识别和评估前列腺癌(PCa)男性患者的癌症特异性焦虑;然而,目前尚无中文版。本研究旨在将MAX-PC英文版翻译成中文,并评估其心理测量学特性。

方法

研究队列包括254名参与者。采用包括克朗巴哈α系数和项目与总分相关性在内的内部一致性来衡量量表的信度。通过探索性因素分析来分析因素结构,并通过将MAX-PC得分与医院焦虑抑郁量表(HADS)的焦虑子量表得分进行比较来评估同时效度。通过将MAX-PC与HADS抑郁子量表进行相关性分析来评估区分效度,同时通过比较不同患者组之间MAX-PC得分的差异来评估判别能力。

结果

MAX-PC中文版显示出良好的信度;总量表及三个子量表(前列腺癌焦虑、PSA焦虑和复发恐惧)的克朗巴哈α系数分别为0.94、0.93、0.82和0.85。探索性因素分析支持了原版量表所确立的三因素结构。尽管区分效度表现欠佳,但该量表显示出良好的同时效度,与HADS焦虑子量表具有很强的相关性(r = 0.71,p < 0.01)。此外,该量表具有通过区分疾病阶段来体现的判别能力。

结论

MAX-PC中文版被证实是一种有效、可靠的工具,因此适用于识别和量化中国PCa患者的癌症特异性焦虑。

相似文献

1
Assessing cancer-specific anxiety in Chinese men with prostate cancer: psychometric evaluation of the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).评估中国前列腺癌男性患者的癌症特异性焦虑:中文版纪念前列腺癌焦虑量表(MAX-PC)的心理测量学评估
Support Care Cancer. 2017 Dec;25(12):3683-3690. doi: 10.1007/s00520-017-3794-5. Epub 2017 Jun 22.
2
Assessing anxiety in Black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).评估前列腺癌黑人男性的焦虑状况:关于前列腺癌纪念焦虑量表(MAX-PC)可靠性和有效性的更多数据。
Support Care Cancer. 2016 Jul;24(7):2905-11. doi: 10.1007/s00520-016-3092-7. Epub 2016 Feb 4.
3
Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.针对处于主动监测中的男性群体的前列腺癌纪念焦虑量表的意大利文化适应性调整。
Tumori. 2018 Jun;104(3):172-178. doi: 10.5301/tj.5000646. Epub 2018 May 9.
4
The Psychometric Properties of Taiwanese Version of the Memorial Anxiety Scale for Prostate Cancer.台湾版前列腺癌焦虑量表的心理计量特性。
J Pain Symptom Manage. 2021 Apr;61(4):824-830. doi: 10.1016/j.jpainsymman.2020.10.013. Epub 2020 Oct 24.
5
Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men.法国男性样本中前列腺癌纪念焦虑量表(MAX-PC)的改编与验证
J Patient Rep Outcomes. 2019 Sep 6;3(1):60. doi: 10.1186/s41687-019-0150-1.
6
Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).评估前列腺癌男性患者的焦虑状况:关于前列腺癌纪念焦虑量表(MAX-PC)可靠性和有效性的更多数据。
Psychosomatics. 2006 Jul-Aug;47(4):340-7. doi: 10.1176/appi.psy.47.4.340.
7
Extending the validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) at the time of prostate biopsy in a racially-mixed population.在一个种族混合人群中,在前列腺活检时扩展前列腺癌纪念焦虑量表(MAX-PC)的有效性。
Psychooncology. 2007 May;16(5):493-8. doi: 10.1002/pon.1107.
8
Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer.荷兰主动监测前列腺癌患者的前列腺癌特异性焦虑:纪念前列腺癌焦虑量表的验证。
Qual Life Res. 2009 Oct;18(8):1061-6. doi: 10.1007/s11136-009-9516-9. Epub 2009 Aug 9.
9
Determining the optimal cut-off scores for the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).确定中文版前列腺癌记忆焦虑量表(MAX-PC)的最佳截断分数。
Health Qual Life Outcomes. 2023 Dec 1;21(1):129. doi: 10.1186/s12955-023-02210-1.
10
The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer.前列腺癌纪念焦虑量表:一种用于测量前列腺癌男性焦虑程度的新量表的验证
Cancer. 2003 Jun 1;97(11):2910-8. doi: 10.1002/cncr.11386.

引用本文的文献

1
Determining the optimal cut-off scores for the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).确定中文版前列腺癌记忆焦虑量表(MAX-PC)的最佳截断分数。
Health Qual Life Outcomes. 2023 Dec 1;21(1):129. doi: 10.1186/s12955-023-02210-1.
2
Fear of cancer recurrence and PSA anxiety in patients with prostate cancer: a systematic review.前列腺癌患者对癌症复发和 PSA 焦虑的恐惧:系统评价。
Support Care Cancer. 2022 Jul;30(7):5577-5589. doi: 10.1007/s00520-022-06876-z. Epub 2022 Feb 1.
3
A novel mHealth App (RyPros) for prostate cancer management: an accessibility and acceptability study.

本文引用的文献

1
Cancer treatment and survivorship statistics, 2016.癌症治疗和生存统计,2016 年。
CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2.
2
Assessing anxiety in Black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).评估前列腺癌黑人男性的焦虑状况:关于前列腺癌纪念焦虑量表(MAX-PC)可靠性和有效性的更多数据。
Support Care Cancer. 2016 Jul;24(7):2905-11. doi: 10.1007/s00520-016-3092-7. Epub 2016 Feb 4.
3
Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations.
一款用于前列腺癌管理的新型移动健康应用程序(RyPros):可及性与可接受性研究。
Transl Androl Urol. 2021 Oct;10(10):3723-3736. doi: 10.21037/tau-21-459.
4
Associations between prostate cancer-related anxiety and health-related quality of life.前列腺癌相关焦虑与健康相关生活质量的关系。
Cancer Med. 2020 Jun;9(12):4467-4473. doi: 10.1002/cam4.3069. Epub 2020 Apr 23.
5
Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men.法国男性样本中前列腺癌纪念焦虑量表(MAX-PC)的改编与验证
J Patient Rep Outcomes. 2019 Sep 6;3(1):60. doi: 10.1186/s41687-019-0150-1.
中国前列腺癌患者与普通人群及其他癌症人群相比的健康相关生活质量。
Support Care Cancer. 2016 Apr;24(4):1849-56. doi: 10.1007/s00520-015-2980-6. Epub 2015 Oct 9.
4
Patient-physician mistrust and violence against physicians in Guangdong Province, China: a qualitative study.中国广东省患者与医生之间的不信任及针对医生的暴力行为:一项定性研究
BMJ Open. 2015 Oct 6;5(10):e008221. doi: 10.1136/bmjopen-2015-008221.
5
[Epidemiology of prostate cancer in China: an overview and clinical implication].[中国前列腺癌的流行病学:概述与临床意义]
Zhonghua Wai Ke Za Zhi. 2015 Apr;53(4):249-52.
6
Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009.1973年至2009年中国上海前列腺癌发病率和死亡率趋势
Prostate. 2015 Oct;75(14):1662-8. doi: 10.1002/pros.23046. Epub 2015 Jul 17.
7
Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up.前列腺癌幸存者的症状、未满足的需求、心理健康状况和健康状态:对重新设计随访的启示
BJU Int. 2016 Jun;117(6B):E10-9. doi: 10.1111/bju.13122. Epub 2015 May 23.
8
Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement.前列腺癌生存者照护指南:美国临床肿瘤学会临床实践指南支持声明。
J Clin Oncol. 2015 Mar 20;33(9):1078-85. doi: 10.1200/JCO.2014.60.2557. Epub 2015 Feb 9.
9
Psychosocial interventions for men with prostate cancer: a Cochrane systematic review.前列腺癌男性患者的心理社会干预:Cochrane系统评价
BJU Int. 2015 Aug;116(2):174-83. doi: 10.1111/bju.12989. Epub 2015 Mar 17.
10
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.